Publications
Download CSV
Download XLSX
Download TXT
Tables
2026 (112)
2025 (1350)
2024 (1422)
2023 (1383)
2022 (1484)
2021 (1501)
2020 (1305)
2019 (1146)
2018 (1213)
2017 (1101)
2016 (996)
2015 (693)
2014 (619)
2013 (473)
2012 (344)
2011 (199)
2010 (72)
2009 (38)
2008 (39)
2007 (13)
2006 (20)
2005 (9)
2004 (3)
2003 (2)
2002 (1)
All (15538)
Labels
Labels list
Labels table
Researchers
Subset
Documentation
About
Contact
Software
Login
van Dam PJ
JSON
CSV
XLSX
TXT
Family name
van Dam
Given name
Pieter-Jan
Initials
PJ
ORCID
ORCID
0000-0001-9074-8271
Affiliations
Center for Oncological Research (CORE), University of Antwerp, Antwerp, Belgium.
HistoGeneX NV, Wilrijk, Antwerp, Belgium.
2 publications
PubMed
DOI
Crossref
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.
De Laere B, Oeyen S, Mayrhofer M, ..., Lindberg J, Dirix LY
Clin. Cancer Res.
25
(6) 1766-1773 [2019-03-15; online 2018-09-12]
PubMed
DOI
Crossref
TP53 Outperforms Other Androgen Receptor Biomarkers to Predict Abiraterone or Enzalutamide Outcome in Metastatic Castration-Resistant Prostate Cancer.
De Laere B, Oeyen S, Mayrhofer M, ..., Lindberg J, Dirix LY
Clin. Cancer Res.
25
(6) 1766-1773 [2019-03-15; online 2018-09-12]
SciLifeLab Data Centre
Publications
9.5.1